Financials

  • Market Capitalization 44.86 M
  • Employee 18
  • Founded 2020
  • CEO N/A
  • Website www.tevogen.com
  • Headquarter Delaware, United States
  • FIGI BBG013395405
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.05
Rapporto prezzo/fatturato
-280.95

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4292
HOWL
Werewolf Therapeutics, Inc. - Common Stock
0.94 USD-3.09%+10.59%+108.89%-27.69%45.68 M USD
4295
MGX
Metagenomi Therapeutics, Inc. - Common Stock
1.19 USD-1.65%-4.80%-0.83%-17.36%44.95 M USD
4303
VERU
Veru Inc. - Common Stock
2.63 USD-4.01%-0.38%+19.00%+10.04%44.84 M USD
4304
GRCE
Grace Therapeutics, Inc. - Common Stock
2.12 USD-1.85%-4.93%+3.92%-46.73%44.60 M USD

Notizie